Octave Strengthens Clinical Expertise in MS and Neurodegenerative Disease – Read the Release

Contact Us

Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis

August 30, 2023inByCommentNo Comments
Click here

© 2025 Octave Bioscience, Inc | 1440 O’Brien Drive, Suite B, Menlo Park, CA 94025 

Connect with us